{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:48Z","timestamp":1786985088010,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515140101"],"award-info":[{"award-number":["2024A1515140101"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800603"],"award-info":[{"award-number":["2018YFA0800603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023B03J1291"],"award-info":[{"award-number":["2023B03J1291"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117437","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:51:49Z","timestamp":1761076309000},"page":"117437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["FKBP38 expression level dictates paclitaxel resistance via interacting with Bcl-2 in endometrial cancer"],"prefix":"10.1016","volume":"243","author":[{"given":"Yunjing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengmiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan Z.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117437_b0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.bcp.2025.117437_b0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.bcp.2025.117437_b0015","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.19.02627","article-title":"Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer","volume":"38","author":"Makker","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2025.117437_b0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the corpus uteri: 2021 update","volume":"155","author":"Koskas","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.bcp.2025.117437_b0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine Neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.bcp.2025.117437_b0030","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1158\/1078-0432.CCR-07-0064","article-title":"Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group","volume":"13","author":"Joerger","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117437_b0035","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1186\/s12885-021-08921-2","article-title":"Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases","volume":"21","author":"Xie","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2025.117437_b0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/annonc\/mdx688","article-title":"Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer","volume":"29","author":"Overman","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bcp.2025.117437_b0045","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2189106","article-title":"Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy","volume":"30","author":"Tu","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2025.117437_b0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2019.01.007","article-title":"A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)","volume":"109","author":"Wang","year":"2019","journal-title":"Eur. J. Cancer (Oxford, England: 1990)"},{"key":"10.1016\/j.bcp.2025.117437_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193094","article-title":"Combination of paclitaxel and PXR antagonist SPA70 reverses paclitaxel-resistant non-small cell lung cancer","volume":"11","author":"Niu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2025.117437_b0060","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117437_b0065","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117437_b0070","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1158\/1078-0432.CCR-03-0707","article-title":"Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy","volume":"10","author":"Sui","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117437_b0075","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J","article-title":"Paclitaxel-induced cell death: where the cell cycle and apoptosis come together","volume":"88","author":"Wang","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2025.117437_b0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-022-01579-9","article-title":"An EHMT2\/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2025.117437_b0085","doi-asserted-by":"crossref","first-page":"e3071","DOI":"10.1038\/cddis.2017.460","article-title":"Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117437_b0090","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1634\/theoncologist.2016-0062","article-title":"Chemotherapy for endometrial cancer in adjuvant and advanced disease settings","volume":"21","author":"Bestvina","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.bcp.2025.117437_b0095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12935-020-01470-x","article-title":"Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway","volume":"20","author":"Liao","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2025.117437_b0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ebiom.2018.12.044","article-title":"Targeting cancer stem cell signature gene SMOC-2 overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma","volume":"40","author":"Lu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2025.117437_b0105","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/ncomms2400","article-title":"Selective escape of proteins from the mitochondria during mitophagy","volume":"4","author":"Saita","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117437_b0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ncb894","article-title":"Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis","volume":"5","author":"Shirane","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117437_b0115","doi-asserted-by":"crossref","first-page":"14253","DOI":"10.1073\/pnas.2332307100","article-title":"Functional identification of distinct sets of antitumor activities mediated by the FKBP gene family","volume":"100","author":"Fong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2025.117437_b0120","doi-asserted-by":"crossref","first-page":"15341","DOI":"10.1074\/jbc.M611594200","article-title":"The Bcl-2 regulator FKBP38-calmodulin-Ca2+ is inhibited by Hsp90","volume":"282","author":"Edlich","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117437_b0125","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/sj.emboj.7600739","article-title":"Bcl-2 regulator FKBP38 is activated by Ca2+\/calmodulin","volume":"24","author":"Edlich","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.117437_b0130","first-page":"3435","article-title":"Expressions of FKBP38 in epithelial ovarian cancer","volume":"16","author":"Yimei Lai","year":"2016","journal-title":"Prog. Modern Biomed."},{"key":"10.1016\/j.bcp.2025.117437_b0135","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117437_b0140","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.7150\/jca.29738","article-title":"Ellagic acid exerts antitumor effects via the PI3K signaling pathway in endometrial cancer","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2025.117437_b0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1878-0261.13031","article-title":"The PI3K\/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings","volume":"16","author":"Shor","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2025.117437_b0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/path.5874","article-title":"Adiponectin deficiency promotes endometrial carcinoma pathogenesis and development via activation of mitogen-activated protein kinase","volume":"257","author":"Yan","year":"2022","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2025.117437_b0155","first-page":"2050","article-title":"An immunosuppressive scoring system to predict recurrence and assist in decision regarding postoperative adjuvant treatment in gastric cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117437_b0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0378-1119(95)00216-S","article-title":"Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motif","volume":"160","author":"Lam","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2025.117437_b0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1522-2683(19990201)20:2<249::AID-ELPS249>3.0.CO;2-F","article-title":"muFKBP38: a novel murine immunophilin homolog differentially expressed in Schwannoma cells and central nervous system neurons in vivo","volume":"20","author":"Pedersen","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bcp.2025.117437_b0170","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","article-title":"Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance","volume":"5","author":"Zheng","year":"2024","journal-title":"Nature Cancer"},{"key":"10.1016\/j.bcp.2025.117437_b0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.22.00628","article-title":"A phase II, two-stage study of letrozole and abemaciclib in estrogen receptor-positive recurrent endometrial cancer","volume":"41","author":"Konstantinopoulos","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117437_b0180","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1200\/JCO.20.01076","article-title":"Carboplatin and paclitaxel for advanced endometrial cancer: final overall survival and adverse event analysis of a phase III trial (NRG oncology\/GOG0209)","volume":"38","author":"Miller","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117437_b0185","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41467-017-02811-7","article-title":"Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation","volume":"9","author":"Zheng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117437_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568009033333754","article-title":"Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation","volume":"3","author":"Yusuf","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2025.117437_b0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-019-1028-z","article-title":"Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer","volume":"38","author":"Chang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.bcp.2025.117437_b0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12951-021-00874-9","article-title":"Graphene oxide (GO)-based nanosheets with combined chemo\/photothermal\/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP)","volume":"19","author":"Guo","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2025.117437_b0205","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cels.2018.03.001","article-title":"Systematic evaluation of molecular networks for discovery of disease genes","volume":"6","author":"Huang","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.bcp.2025.117437_b0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cels.2016.12.011","article-title":"Genome-scale networks link neurodegenerative disease genes to \u03b1-synuclein through specific molecular pathways","volume":"4","author":"Khurana","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.bcp.2025.117437_b0215","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac052","article-title":"The single-sample network module biomarkers (sNMB) method reveals the pre-deterioration stage of disease progression","volume":"14","author":"Zhong","year":"2022","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117437_b0220","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.cell.2013.10.020","article-title":"Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism","volume":"155","author":"Willsey","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117437_b0225","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.1247363","article-title":"Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders","volume":"343","author":"Novarino","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117437_b0230","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/ars.2009.3050","article-title":"Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells","volume":"13","author":"Low","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2025.117437_b0235","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/sj.emboj.7601126","article-title":"Bcl-2 changes conformation to inhibit Bax oligomerization","volume":"25","author":"Dlugosz","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.117437_b0240","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2025.117437_b0245","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.biopha.2017.04.043","article-title":"Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line","volume":"90","author":"Shi","year":"2017","journal-title":"Biomed. Pharmacother."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:57:03Z","timestamp":1775797023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"alternative-id":["S0006295225007026"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117437","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FKBP38 expression level dictates paclitaxel resistance via interacting with Bcl-2 in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117437"}}